ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 015351909. A total of 7 filers reported holding ALEXION PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,020,000 | +156.0% | 18,000 | +146.6% | 0.00% | +100.0% |
| Q4 2019 | $789,000 | +55.0% | 7,300 | +40.4% | 0.00% | 0.0% |
| Q3 2019 | $509,000 | +33.9% | 5,200 | +79.3% | 0.00% | – |
| Q2 2019 | $380,000 | +56.4% | 2,900 | +61.1% | 0.00% | – |
| Q1 2019 | $243,000 | -26.6% | 1,800 | -47.1% | 0.00% | – |
| Q4 2018 | $331,000 | -63.9% | 3,400 | -48.5% | 0.00% | -100.0% |
| Q3 2018 | $917,000 | -12.1% | 6,600 | -21.4% | 0.00% | 0.0% |
| Q2 2018 | $1,043,000 | +23.1% | 8,400 | +10.5% | 0.00% | 0.0% |
| Q1 2018 | $847,000 | -78.9% | 7,600 | -77.4% | 0.00% | -66.7% |
| Q4 2017 | $4,018,000 | -10.2% | 33,600 | +5.3% | 0.00% | -25.0% |
| Q3 2017 | $4,475,000 | +64.2% | 31,900 | +42.4% | 0.00% | +33.3% |
| Q2 2017 | $2,725,000 | -27.5% | 22,400 | -27.7% | 0.00% | -25.0% |
| Q1 2017 | $3,758,000 | -40.1% | 31,000 | -39.6% | 0.00% | -33.3% |
| Q4 2016 | $6,277,000 | +60.1% | 51,300 | +60.3% | 0.01% | +50.0% |
| Q3 2016 | $3,921,000 | +45.4% | 32,000 | +38.5% | 0.00% | +33.3% |
| Q2 2016 | $2,697,000 | +53.8% | 23,100 | +83.3% | 0.00% | +50.0% |
| Q1 2016 | $1,754,000 | -17.9% | 12,600 | +12.5% | 0.00% | 0.0% |
| Q4 2015 | $2,136,000 | +167.7% | 11,200 | +119.6% | 0.00% | +100.0% |
| Q3 2015 | $798,000 | -65.2% | 5,100 | -59.8% | 0.00% | -50.0% |
| Q2 2015 | $2,296,000 | +76.6% | 12,700 | +69.3% | 0.00% | +100.0% |
| Q1 2015 | $1,300,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|